Savvy Advisors Inc’s AstraZeneca AZN Stock Holding History

Savvy Advisors Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$468K	Buy	2,373 +451	+23%	+$87K	0.01%	703
2025 Q4	$353K	Buy	+1,922	New	+$337K	0.01%	706
2025 Q2	–	Sell	-1,417	Closed	-$208K	–	651
2025 Q1	$208K	Buy	+1,417	New	+$205K	0.02%	487
2024 Q4	–	Sell	-1,356	Closed	-$211K	–	452
2024 Q3	$211K	Buy	+1,356	New	+$219K	0.04%	327

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Savvy Advisors Inc's AZN Position: Q1 2026 in Review

Savvy Advisors Inc increased its AstraZeneca (AZN) stake by 23% in Q1 2026, buying an estimated $87K and bringing the position to 2,373 shares worth $468K. The position accounts for 0.01% of the portfolio, ranked #703.

Savvy Advisors Inc first reported a position in AZN in Q3 2024 and has held it in 4 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Savvy Advisors Inc held 2,373 shares of AstraZeneca worth $468K as of Q1 2026.
Savvy Advisors Inc bought 451 AstraZeneca shares in Q1 2026, an estimated $87K.
AstraZeneca made up 0.01% of Savvy Advisors Inc's portfolio in Q1 2026, its #703 holding.
Savvy Advisors Inc first reported a position in AstraZeneca in Q3 2024 and has held it in 4 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.